Citation
Pavlides, Gregory, et al. "Current Management and Quality of Life of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention in Greece: 12-Month Results From Antiplatelet Therapy Observational Study II (APTOR II)." Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese, vol. 54, no. 4, 2013, pp. 255-63.
Pavlides G, Drossinos V, Dafni C, et al. Current management and quality of life of patients with acute coronary syndrome undergoing percutaneous coronary intervention in Greece: 12-Month results from antiplatelet therapy observational study II (APTOR II). Hellenic J Cardiol. 2013;54(4):255-63.
Pavlides, G., Drossinos, V., Dafni, C., Altsitzoglou, P., Antoniadis, A., Manolis, A. S., Tsioufis, C., Goudevenos, I., Kochiadakis, G., & Alexopoulos, D. (2013). Current management and quality of life of patients with acute coronary syndrome undergoing percutaneous coronary intervention in Greece: 12-Month results from antiplatelet therapy observational study II (APTOR II). Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese, 54(4), 255-63.
Pavlides G, et al. Current Management and Quality of Life of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention in Greece: 12-Month Results From Antiplatelet Therapy Observational Study II (APTOR II). Hellenic J Cardiol. 2013 Jul-Aug;54(4):255-63. PubMed PMID: 23912917.
TY - JOUR
T1 - Current management and quality of life of patients with acute coronary syndrome undergoing percutaneous coronary intervention in Greece: 12-Month results from antiplatelet therapy observational study II (APTOR II).
AU - Pavlides,Gregory,
AU - Drossinos,Vangelis,
AU - Dafni,Chaido,
AU - Altsitzoglou,Petros,
AU - Antoniadis,Aiantas,
AU - Manolis,Antonios S,
AU - Tsioufis,Costas,
AU - Goudevenos,Ioannis,
AU - Kochiadakis,George,
AU - Alexopoulos,Dimitrios,
PY - 2013/8/6/entrez
PY - 2013/8/6/pubmed
PY - 2014/4/2/medline
SP - 255
EP - 63
JF - Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
JO - Hellenic J Cardiol
VL - 54
IS - 4
N2 - INTRODUCTION: We describe the current management of patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI) over 12 months in Greece. METHODS: This was a prospective observational study in ACS patients undergoing PCI from September 2008 to April 2009, capturing practices over 12 months at 22 sites that enrolled 558 eligible patients. RESULTS: A total of 351 patients suffered from unstable angina or non-ST elevation myocardial infarction (UA/ NSTEMI), while 207 patients suffered from ST-elevation myocardial infarction (STEMI). For the UA/NSTEMI group, the median age was 64 years (interquartile range: 55-73), while for the STEMI group the median age was 56 years (interquartile range: 49-66). Stents were placed in 96.4% of patients: bare-metal stents alone were placed in 19% of patients, drug-eluting stents alone in 77.5% of patients, and both types of stent in 3.5% of patients. 74% of UA/NSTEMI patients and 87% of STEMI patients received the first antiplatelet loading dose within 1 day of the episode. 76% of UA/NSTEMI patients underwent PCI within 3 days following the initial ACS symptoms, while 67% of STEMI patients underwent PCI within 1 day of the ACS symptoms. Follow-up data were available for 540 (96.8%) patients. The percentages of patients on antiplatelet therapy and on other medications at the time of hospital discharge and at 12 months post-PCI were as follows: aspirin 98%, 97%; clopidogrel 99%, 96%; statins 81%, 79%; beta-blockers 73%, 72%; calcium blockers 11%, 11%; angiotensin II receptor blockers/angiotensin-converting enzyme inhibitors 64%, 62%; proton-pump inhibitors 39%, 35%. CONCLUSIONS: In ACS patients treated with PCI in Greece, dual antiplatelet treatment is maintained in a very high percentage through 1 year post-procedure, and drug-eluting stent use is also high.
SN - 2241-5955
UR - https://www.unboundmedicine.com/medline/citation/23912917/Current_management_and_quality_of_life_of_patients_with_acute_coronary_syndrome_undergoing_percutaneous_coronary_intervention_in_Greece:_12_Month_results_from_antiplatelet_therapy_observational_study_II__APTOR_II__
L2 - https://www.hellenicjcardiol.org/archive/full_text/2013+54/4/2013_4_255.pdf
DB - PRIME
DP - Unbound Medicine
ER -